Supply chain priorities of U.S. provider and pharma/life sciences executives 2021

According to a survey conducted among health service provider and pharmaceutical/life science executives in August-September 2020, 50 percent of pharmaceutical/life sciences executives said their pripority will be to improve supply chain transparency in 2021. This statistic illustrates the supply chain priorities in 2021 reported by U.S. health services provider and pharma/life sciences executives.

根据2020年8月至9月间对医疗服务提供者和制药/生命科学行业高管进行的调查，50%的制药/生命科学行业高管表示，他们将在2021年的首要任务中着重提升供应链的透明度。此统计数据揭示了美国医疗服务提供者和制药/生命科学行业高管在2021年所报告的供应链优先级。